NDC Compounded Drug 73271-1217-1 Thiamine Hydrochloride; Niacinamide; Pyridoxine Hydrochloride; Sodium Ascorbate; Calcium Cation; Magnesium Cation

Solution Intravenous

Table of Contents

    1. Compounded Product Information
    2. Frequently Asked Questions

Compounded Drug Product Information

NDC Product Code 73271-1217
NDC Package Code 73271-1217-1
11-Digit NDC Billing Format NDC Format for Billing
For insurance billing purposes the Centers for Medicare & Medicaid Services (CMS) created an 11 digit NDC derivative identifier. If the NDC Package code is less than 11 digits the code must be padded with leading zeros. The leading zeros must be added to the appropriate segment to create a 5-4-2 configuration.		 73271121701
Package Description 30 mL in 1 VIAL
Product Type What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.		 Human Compounded Drug
Proprietary Name What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.		 Myers Cocktail Vitamin B1 Vitamin B3/vitamin B6/vitamin C/ Calcium/ Magnesium
Non-Proprietary Name What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.		 Myers Cocktail Vitamin B1 Vitamin B3/vitamin B6/vitamin C/ Calcium/ Magnesium
Substance Name What is the Substance Name?
An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.		 Thiamine Hydrochloride; Niacinamide; Pyridoxine Hydrochloride; Sodium Ascorbate; Calcium Cation; Magnesium Cation
Dosage Form Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Route Name Intravenous - Administration within or into a vein or veins.
Marketing Category OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Code 73271
Labeler Name What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.		 Right Value Drug Stores Llc Dba Carie Boyd's Prescription Shop
Substance Name Thiamine Hydrochloride; Niacinamide; Pyridoxine Hydrochloride; Sodium Ascorbate; Calcium Cation; Magnesium Cation
Active Ingredients Information 3.3 mg/1 mL; 3.3 mg/1 mL; 3.3 mg/1 mL; 10 mg/1 mL; 3.3 mg/1 mL; 3.3 mg/1 mL
Reporting Period 2023-1

Frequently Asked Questions

What is the NDC number assigned to Myers Cocktail Vitamin B1 Vitamin B3/vitamin B6/vitamin C/ Calcium/ Magnesium?

Myers Cocktail Vitamin B1 Vitamin B3/vitamin B6/vitamin C/ Calcium/ Magnesium was assigned by its manufacturer with NDC product code 73271-1217. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.

Which are the NDC package codes for Myers Cocktail Vitamin B1 Vitamin B3/vitamin B6/vitamin C/ Calcium/ Magnesium?

The NDC package code 73271-1217-1 was assigned to a 30 mL in 1 VIAL of thiamine hydrochloride; niacinamide; pyridoxine hydrochloride; sodium ascorbate; calcium cation; magnesium cation administered intravenous via solution.

Who manufactures this product?

Myers Cocktail Vitamin B1 Vitamin B3/vitamin B6/vitamin C/ Calcium/ Magnesium is manufactured by an outsourced facility and labeled by Right Value Drug Stores Llc Dba Carie Boyd's Prescription Shop. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.